RemeGen (688331.SH) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Nov28

BlackRock cuts holdings in RemeGen by 185,500 shares

12:15

Nov26

East China Securities Issues Buy Rating for Rongchang Biotechnology

07:34

Nov18

CFC 上调荣昌生物目标价及盈利预测

01:17

Nov11

Rongchang Biotech Reports Strong Revenue Growth but Persistent Losses in Q3 2025

09:57

Nov5

荣昌生物 3Q25 Performance Slightly Better Than Expected, PD-1/VEGF Dual Antibody Development Strategy Revealed

03:02

Nov3

Rongchang Biotech Signs 400 Million RMB Wealth Management Product Agreement with SPDB Yantai Branch

09:18

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 621.88 M, Net Income -101.13 M, EPS -0.183

Aug22

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 571.98 M, Net Income -195.42 M, EPS -0.3681

Apr28

Earning Release(CST)

FY2025 Q1 Earning Release (CNY) Revenue 525.97 M, Net Income -254.14 M, EPS -0.46

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More